Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

BabyScreen+ newborn screening

Gene: AMT

Amber List (moderate evidence)

AMT (aminomethyltransferase)
EnsemblGeneIds (GRCh38): ENSG00000145020
EnsemblGeneIds (GRCh37): ENSG00000145020
OMIM: 238310, Gene2Phenotype
AMT is in 12 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

I don't know

Severe infantile forms: treatment does not currently alter outcomes.

Attenuated forms can have onset in childhood, therapy with sodium benzoate and NMDA (The N-methyl-D-aspartate receptor) receptor site antagonists (dextromethorphan, ketamine) but uncertainty about effectiveness.
Created: 31 May 2023, 1:47 a.m. | Last Modified: 31 May 2023, 1:47 a.m.
Panel Version: 0.2158
Well established gene-disease association.

Variable severity, can present in infancy or childhood.

No specific treatment available.
Created: 21 Sep 2022, 8:48 a.m. | Last Modified: 21 Sep 2022, 8:48 a.m.
Panel Version: 0.83

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Glycine encephalopathy MIM#605899

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
  • BabySeq Category A gene
Phenotypes
  • Glycine encephalopathy MIM#605899
Tags
treatable metabolic
OMIM
238310
Clinvar variants
Variants in AMT
Penetrance
None
Publications
Panels with this gene

History Filter Activity

28 Jul 2024, Gel status: 2

Set Phenotypes

Tommy Li (Murdoch Children's Research Institute)

Added phenotypes Glycine encephalopathy MIM#605899 for gene: AMT

31 May 2023, Gel status: 2

Added Tag, Added Tag

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Tag treatable tag was added to gene: AMT. Tag metabolic tag was added to gene: AMT.

31 May 2023, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: AMT were set to

31 May 2023, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: amt has been classified as Amber List (Moderate Evidence).

21 Sep 2022, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: amt has been classified as Red List (Low Evidence).

21 Sep 2022, Gel status: 1

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: AMT were changed from Hyperglycinaemia, non-ketotic to Glycine encephalopathy MIM#605899

21 Sep 2022, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: amt has been classified as Red List (Low Evidence).

18 Sep 2022, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: AMT was added gene: AMT was added to gNBS. Sources: BabySeq Category A gene,Expert Review Green Mode of inheritance for gene: AMT was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: AMT were set to Hyperglycinaemia, non-ketotic